Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed.

Matrix metalloproteinases (MMPs) catalyze extracellular matrix degradation. Control of their activity is a promising target for therapy of diseases characterized by abnormal connective tissue turnover. MMPs are expressed as latent proenzymes that are activated by proteolytic cleavage that triggers a conformational change in the propeptide (cysteine switch). The structure of proMMP-2 reveals how the propeptide shields the catalytic cleft and that the cysteine switch may operate through cleavage of loops essential for propeptide stability.

[1]  B. Matthews,et al.  An interactive computer graphics study of thermolysin-catalyzed peptide cleavage and inhibition by N-carboxymethyl dipeptides. , 1984, Biochemistry.

[2]  R. Fridman,et al.  Kinetic Analysis of the Binding of Human Matrix Metalloproteinase-2 and -9 to Tissue Inhibitor of Metalloproteinase (TIMP)-1 and TIMP-2* , 1997, The Journal of Biological Chemistry.

[3]  M. Seiki,et al.  Intermolecular Autolytic Cleavage Can Contribute to the Activation of Progelatinase A by Cell Membranes (*) , 1995, The Journal of Biological Chemistry.

[4]  C. Ioannou,et al.  Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain. , 1993, European journal of biochemistry.

[5]  L. Liotta,et al.  Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. , 1983, The Journal of biological chemistry.

[6]  M. Walid Qoronfleh,et al.  Structure of human neutrophil collagenase reveals large S1′ specificity pocket , 1994, Nature Structural Biology.

[7]  Z. Werb,et al.  Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. , 1996, Current opinion in cell biology.

[8]  A M Hassell,et al.  Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. , 1994, Science.

[9]  J. Springer,et al.  Stromelysin‐1: Three‐dimensional structure of the inhibited catalytic domain and of the C‐truncated proenzyme , 1995, Protein science : a publication of the Protein Society.

[10]  J. Ghuysen,et al.  Binding site‐shaped repeated sequences of bacterial wall peptidoglycan hydrolases , 1994, FEBS letters.

[11]  A. Strongin,et al.  Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. , 1993, The Journal of biological chemistry.

[12]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[13]  H. Birkedal‐Hansen,et al.  The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  W. Bode,et al.  The C‐terminal (haemopexin‐like) domain structure of human gelatinase A (MMP2): structural implications for its function , 1996, FEBS letters.

[15]  A. Strongin,et al.  Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase. , 1992, The Journal of biological chemistry.

[16]  E. Lattman,et al.  Crystal structure of the haemopexin-like C-terminal domain of gelatinase A , 1995, Nature Structural Biology.

[17]  J. O'Connell,et al.  The role of the C-terminal domain in collagenase and stromelysin specificity. , 1992, The Journal of biological chemistry.

[18]  William G. Stetler-Stevenson,et al.  Matrix Metalloproteinases , 1997, Drugs & aging.

[19]  Axel T. Brunger,et al.  X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .

[20]  M. Browner,et al.  Crystal structures of matrilysin-inhibitor complexes , 1995 .

[21]  C. López-Otín,et al.  The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain. , 1996, Journal of molecular biology.

[22]  T. Hurskainen,et al.  Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. , 1992, Cancer research.

[23]  J. Frère,et al.  Structure of a Zn2+-containing D-alanyl-D-alanine-cleaving carboxypeptidase at 2.5 Å resolution , 1982, Nature.

[24]  H. Birkedal‐Hansen.  Proteolytic remodeling of extracellular matrix. , 1995, Current opinion in cell biology.

[25]  M. Browner,et al.  Matrilysin-inhibitor complexes: common themes among metalloproteases. , 1996, Biochemistry.

[26]  B. Hazleman,et al.  Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. , 1995, Structure.

[27]  P. Slocombe,et al.  The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. , 1993, Biochemistry.

[28]  K. Suzuki,et al.  Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. , 1990, Biochemistry.

[29]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[30]  J. Springer,et al.  The NMR structure of the inhibited catalytic domain of human stromelysin–1 , 1994, Nature Structural Biology.

[31]  L. Kotra,et al.  Matrix metalloproteinases: structures, evolution, and diversification , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[33]  E. Kohn,et al.  Molecular insights into cancer invasion: strategies for prevention and intervention. , 1995, Cancer research.

[34]  W. Bode,et al.  Structural features of a superfamily of zinc-endopeptidases: the metzincins. , 1995, Current opinion in structural biology.

[35]  I. Campbell,et al.  Solution structure of a type 2 module from fibronectin: implications for the structure and function of the gelatin-binding domain. , 1997, Structure.

[36]  K. Constantine,et al.  Refined solution structure and ligand-binding properties of PDC-109 domain b. A collagen-binding type II domain. , 1992, Journal of molecular biology.